Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tanja D de Gruijl"'
Autor:
Hans van Vliet, Paul W. H. I. Parren, Rieneke van de Ven, Jana Vree, Roeland Lameris, Tanja D. de Gruijl, Renate de Boer, Anita G.M. Stam, George L. Scheffer, Arnon P. Kater, Steven T. Pals, Mark-David Levin, Rob C. Roovers, Iris de Weerdt
Publikováno v:
Cancer immunology research, 9(1), 50-61. American Association for Cancer Research Inc.
Cancer Immunology Research, 9(1), 50-61. AMER ASSOC CANCER RESEARCH
de Weerdt, I, Lameris, R, Scheffer, G L, Vree, J, de Boer, R, Stam, A G, van de Ven, R, Levin, M-D, Pals, S T, Roovers, R C, Parren, P W H I, de Gruijl, T D, Kater, A P & van der Vliet, H J 2021, ' A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell-Mediated Antitumor Responses in Human B-cell Malignancies ', Cancer Immunology Research, vol. 9, no. 1, pp. 50-61 . https://doi.org/10.1158/2326-6066.CIR-20-0138
Cancer Immunology Research, 9(1), 50-61. American Association for Cancer Research Inc.
Cancer Immunology Research, 9(1), 50-61. AMER ASSOC CANCER RESEARCH
de Weerdt, I, Lameris, R, Scheffer, G L, Vree, J, de Boer, R, Stam, A G, van de Ven, R, Levin, M-D, Pals, S T, Roovers, R C, Parren, P W H I, de Gruijl, T D, Kater, A P & van der Vliet, H J 2021, ' A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell-Mediated Antitumor Responses in Human B-cell Malignancies ', Cancer Immunology Research, vol. 9, no. 1, pp. 50-61 . https://doi.org/10.1158/2326-6066.CIR-20-0138
Cancer Immunology Research, 9(1), 50-61. American Association for Cancer Research Inc.
Novel T cell-based therapies for the treatment of B-cell malignancies, such as chronic lymphocytic leukemia (CLL) and multiple myeloma (MM), are thought to have strong potential. Progress, however, has been hampered by low efficacy and high toxicity.
Autor:
Martino Ambrosini, Sanne Duinkerken, Juan J. Garcia-Vallejo, Tanja D. de Gruijl, Lisa Rutte, Hakan Kalay, Sophie K. Horrevorts, Yvette van Kooyk
Publikováno v:
Duinkerken, S, Horrevorts, S K, Kalay, H, Ambrosini, M, Rutte, L, de Gruijl, T D, Garcia-Vallejo, J J & van Kooyk, Y 2019, ' Glyco-dendrimers as intradermal anti-tumor vaccine targeting multiple skin DC subsets ', Theranostics, vol. 9, no. 20, pp. 5797-5809 . https://doi.org/10.7150/thno.35059
Theranostics, 9, 5797-5809
Theranostics
Theranostics, 9(20), 5797-5809. Ivyspring International Publisher
Theranostics, 9, 20, pp. 5797-5809
Theranostics, 9, 5797-5809
Theranostics
Theranostics, 9(20), 5797-5809. Ivyspring International Publisher
Theranostics, 9, 20, pp. 5797-5809
Contains fulltext : 215802.pdf (Publisher’s version ) (Open Access) The human skin is an attractive anti-tumor vaccination site due to the vast network of dendritic cell (DC) subsets that carry antigens to the draining lymph nodes and stimulate tum
Autor:
Fenna Bohme, John P. Veluchamy, Tanja D. de Gruijl, Hans van Vliet, Jan Spanholtz, María Delso-Vallejo, Nina Kok, Volker Huppert, Ruth Seggewiss-Bernhardt
Publikováno v:
Scientific Reports, 7:43873. Nature Publishing Group
Veluchamy, J P, Delso-Vallejo, M, Kok, N, Bohme, F, Seggewiss-Bernhardt, R, Van Der Vliet, H J, De Gruijl, T D, Huppert, V & Spanholtz, J 2017, ' Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function ', Scientific Reports, vol. 7, 43873 . https://doi.org/10.1038/srep43873
Scientific Reports
Veluchamy, J P, Delso-Vallejo, M, Kok, N, Bohme, F, Seggewiss-Bernhardt, R, Van Der Vliet, H J, De Gruijl, T D, Huppert, V & Spanholtz, J 2017, ' Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function ', Scientific Reports, vol. 7, 43873 . https://doi.org/10.1038/srep43873
Scientific Reports
Advancements in multi-colour fluorescence activated cell sorting (FACS) panel warrant harmonized procedures to obtain comparable data between various laboratories. The intensifying clinical exploration of Natural Killer (NK) cell-based immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63120cd0d6125521f69e77e4e3331038
https://research.vumc.nl/en/publications/f8de79a6-0ed1-4ac4-9bfa-34c7e6e79b14
https://research.vumc.nl/en/publications/f8de79a6-0ed1-4ac4-9bfa-34c7e6e79b14
Autor:
Anne-Marie Cleton-Jansen, Vincenzo Canzonieri, Monique A. J. van Eijndhoven, Laura Roncuzzi, Sulev Kõks, Tonny Lagerweij, Nicoletta Zini, Massimo Dominici, Maria Pérez-Lanzón, Roberta Bonafede, Tanja D. de Gruijl, Silvia Cervo, Aare Märtson, Nicolas Léveillé, D. Michiel Pegtel, Nicola Baldini, Thomas Wurdinger, Xuan Dung Ho, Agostino Steffan, Katre Maasalu, Ekaterina S. Jordanova, S. Rubina Baglio, Giulia Grisendi, M. Greco, Sonia A. Melo, Sinéad M. Lougheed
Publikováno v:
Clinical Cancer Research, 23(14), 3721-3733. American Association for Cancer Research Inc.
Clinical cancer research, 23(14), 3721-3733. American Association for Cancer Research Inc.
Clinical Cancer Research, 23(14), 3721-3733
Baglio, S R, Lagerweij, T, Pérez-Lanzón, M, Ho, X D, Léveillé, N, Melo, S A, Cleton-Jansen, A M, Jordanova, E S, Roncuzzi, L, Greco, M, Van Eijndhoven, M A J, Grisendi, G, Dominici, M, Bonafede, R, Lougheed, S M, De Gruijl, T D, Zini, N, Cervo, S, Steffan, A, Canzonieri, V, Martson, A, Maasalu, K, Köks, S, Wurdinger, T, Baldini, N & Pegtel, D M 2017, ' Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression ', Clinical Cancer Research, vol. 23, no. 14, pp. 3721-3733 . https://doi.org/10.1158/1078-0432.CCR-16-2726
Clinical cancer research, 23(14), 3721-3733. American Association for Cancer Research Inc.
Clinical Cancer Research, 23(14), 3721-3733
Baglio, S R, Lagerweij, T, Pérez-Lanzón, M, Ho, X D, Léveillé, N, Melo, S A, Cleton-Jansen, A M, Jordanova, E S, Roncuzzi, L, Greco, M, Van Eijndhoven, M A J, Grisendi, G, Dominici, M, Bonafede, R, Lougheed, S M, De Gruijl, T D, Zini, N, Cervo, S, Steffan, A, Canzonieri, V, Martson, A, Maasalu, K, Köks, S, Wurdinger, T, Baldini, N & Pegtel, D M 2017, ' Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression ', Clinical Cancer Research, vol. 23, no. 14, pp. 3721-3733 . https://doi.org/10.1158/1078-0432.CCR-16-2726
Purpose: Human osteosarcoma is a genetically heterogeneous bone malignancy with poor prognosis despite the employment of aggressive chemotherapy regimens. Because druggable driver mutations have not been established, dissecting the interactions betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6fc995d21f815df8513d6bb494316e5
https://hdl.handle.net/11368/2967826
https://hdl.handle.net/11368/2967826
Autor:
Rieneke van de Ven, Tanja D. de Gruijl, Anneke W. Reurs, Jelle J. Lindenberg, George L. Scheffer, Rik J. Scheper
Publikováno v:
van de Ven, R, Lindenberg, J J, Reurs, A W, Scheper, R J, Scheffer, G L & de Gruijl, T D 2012, ' Preferential Langerhans cell differentiation from CD34(+) precursors upon introduction of ABCG2 (BCRP). ', Immunology and cell biology, vol. 90, no. 2, pp. 206-215 . https://doi.org/10.1038/icb.2011.25
Immunology and cell biology, 90(2), 206-215. Springer Nature
Immunology and cell biology, 90(2), 206-215. Springer Nature
Epidermal Langerhans cells (LC) and dermal interstitial dendritic cells (IDC) were found to express the ATP-binding cassette (ABC) transporter breast cancer resistance protein (BCRP; ABCG2). Also, low BCRP expression was present on CD34(+) blood DC p
Autor:
Wilfried A.M. Bakker, Leo A. van der Pol, Gerco van Eikenhorst, Gerard van de Weerd, Tanja D. de Gruijl, Dinja Oosterhoff
Publikováno v:
BioMed Research International
BioMed Research International, 2015:358462. Hindawi Publishing Corporation
BioMed Research International, Vol 2015 (2015)
Oosterhoff, D, van de Weerd, G, van Eikenhorst, G, de Gruijl, T D, van der Pol, L A & Bakker, W A M 2015, ' Hematopoietic Cancer Cell Lines Can Support Replication of Sabin Poliovirus Type 1 ', BioMed Research International, vol. 2015, 358462 . https://doi.org/10.1155/2015/358462
BioMed Research International, 2015:358462. Hindawi Publishing Corporation
BioMed Research International, Vol 2015 (2015)
Oosterhoff, D, van de Weerd, G, van Eikenhorst, G, de Gruijl, T D, van der Pol, L A & Bakker, W A M 2015, ' Hematopoietic Cancer Cell Lines Can Support Replication of Sabin Poliovirus Type 1 ', BioMed Research International, vol. 2015, 358462 . https://doi.org/10.1155/2015/358462
Viral vaccines can be produced in adherent or in suspension cells. The objective of this work was to screen human suspension cell lines for the capacity to support viral replication. As the first step, it was investigated whether poliovirus can repli
Autor:
Hans Baumeister, Saskia J. A. M. Santegoets, Erik Hooijberg, Ying Poi Liu, Sinéad M. Lougheed, Alfons J.M. van den Eertwegh, Steffen Goletz, Marco W.J. Schreurs, Allan J. Masterson, Esther W. M. Kueter, Tanja D. de Gruijl, Rik J. Scheper
Publikováno v:
Santegoets, S J A M, Schreurs, M W J, Masterson, A J, Liu, Y P, Goletz, S, Baumeister, H, Kueter, E W M, Lougheed, S M, Van Den Eertwegh, A J M, Scheper, R J, Hooijberg, E & De Gruijl, T D 2006, ' In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line ', Cancer Immunology, Immunotherapy, vol. 55, no. 12, pp. 1480-1490 . https://doi.org/10.1007/s00262-006-0142-x
Cancer Immunology, Immunotherapy, 55(12), 1480-1490. Springer Science and Business Media Deutschland GmbH
Cancer Immunology, Immunotherapy, 55(12), 1480-1490. Springer Science and Business Media Deutschland GmbH
The adoptive transfer of in vitro-induced and expanded tumor-specific cytotoxic T lymphocytes (CTL) presents a promising immunotherapeutic approach for the treatment of cancer. The in vitro induction of tumor-reactive CTL requires repeated stimulatio
Autor:
Godefridus J. Peters, Ben A. C. Dijkmans, Rik J. Scheper, Ruud Oerlemans, Debby den Uyl, Tanja D. de Gruijl, Marjon Al, Elena T. Chan, Yehuda G. Assaraf, Gerrit Jansen, Joost W. van der Heijden, Christopher J. Kirk, George L. Scheffer, Sue Ellen Verbrugge
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 341(1)
Bortezomib (BTZ), a registered proteasome inhibitor (PI) for multiple myeloma, has also been proposed as a potential antirheumatic agent. Its reported side effects, however, make it unappealing for long-term administration, and resistance may also de
Autor:
Saskia J. A. M. Santegoets, Rik J. Scheper, Herbert M. Pinedo, Pieter C. van der Sluis, Tanja D. de Gruijl, Allan J. Masterson, Sinéad M. Lougheed, Alfons J.M. van den Eertwegh, Fluitsma Dm
Publikováno v:
Santegoets, S J A M, Masterson, A J, Van Der Sluis, P C, Lougheed, S M, Fluitsma, D M, Van Den Eertwegh, A J M, Pinedo, H M, Scheper, R J & De Gruijl, T D 2006, ' A CD34 + human cell line model of myeloid dendritic cell differentiation : Evidence for a CD14 + CD11b + Langerhans cell precursor ', Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1337-1344 . https://doi.org/10.1189/jlb.0206111
Journal of Leukocyte Biology, 80(6), 1337-1344. FASEB
Journal of Leukocyte Biology, 80(6), 1337-1344. FASEB
The study of early events in dendritic cell (DC) differentiation is hampered by the lack of homogeneous primary cell systems that allow the study of cytokine-driven, transitional DC differentiation steps. The CD34+ acute myeloid leukemia cell line MU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4934e2c94049bed55cac83f900a32991
https://research.vumc.nl/en/publications/d372cc28-e626-4e35-b5bc-3c632ccbdd70
https://research.vumc.nl/en/publications/d372cc28-e626-4e35-b5bc-3c632ccbdd70
Autor:
Donna Fluitsma, Lot de Witte, Marein A. W. P. de Jong, Teunis B.H. Geijtenbeek, Marjorie Pion, Yvette van Kooyk, Tanja D. de Gruijl, Alexey A. Nabatov, Vincent Piguet
Publikováno v:
Nature medicine, 13(3), 367-371. Nature Publishing Group
de Witte, L, Nabatov, A, Pion, M, Fluitsma, D, de Jong, M A W P, de Gruijl, T, Piguet, V, van Kooyk, Y & Geijtenbeek, T B H 2007, ' Langerin is a natural barrier to HIV-1 transmission by Langerhans cells ', Nature Medicine, vol. 13, no. 3, pp. 367-71 . https://doi.org/10.1038/nm1541
Nature Medicine, 13(3), 367-71. Nature Publishing Group
de Witte, L, Nabatov, A, Pion, M, Fluitsma, D, de Jong, M A W P, de Gruijl, T, Piguet, V, van Kooyk, Y & Geijtenbeek, T B H 2007, ' Langerin is a natural barrier to HIV-1 transmission by Langerhans cells ', Nature Medicine, vol. 13, no. 3, pp. 367-71 . https://doi.org/10.1038/nm1541
Nature Medicine, 13(3), 367-71. Nature Publishing Group
Human immunodeficiency virus-1 (HIV-1) is primarily transmitted sexually. Dendritic cells (DCs) in the subepithelium transmit HIV-1 to T cells through the C-type lectin DC-specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin (DC-SIG